全文获取类型
收费全文 | 714篇 |
免费 | 60篇 |
国内免费 | 18篇 |
专业分类
儿科学 | 2篇 |
妇产科学 | 4篇 |
基础医学 | 138篇 |
口腔科学 | 6篇 |
临床医学 | 38篇 |
内科学 | 77篇 |
皮肤病学 | 14篇 |
神经病学 | 61篇 |
特种医学 | 17篇 |
外科学 | 19篇 |
综合类 | 40篇 |
预防医学 | 26篇 |
眼科学 | 2篇 |
药学 | 281篇 |
中国医学 | 4篇 |
肿瘤学 | 63篇 |
出版年
2023年 | 8篇 |
2022年 | 7篇 |
2021年 | 18篇 |
2020年 | 27篇 |
2019年 | 14篇 |
2018年 | 23篇 |
2017年 | 26篇 |
2016年 | 23篇 |
2015年 | 30篇 |
2014年 | 38篇 |
2013年 | 85篇 |
2012年 | 30篇 |
2011年 | 44篇 |
2010年 | 42篇 |
2009年 | 28篇 |
2008年 | 41篇 |
2007年 | 29篇 |
2006年 | 25篇 |
2005年 | 25篇 |
2004年 | 29篇 |
2003年 | 31篇 |
2002年 | 17篇 |
2001年 | 11篇 |
2000年 | 14篇 |
1999年 | 12篇 |
1998年 | 10篇 |
1997年 | 14篇 |
1996年 | 9篇 |
1995年 | 11篇 |
1994年 | 12篇 |
1993年 | 3篇 |
1992年 | 10篇 |
1991年 | 6篇 |
1990年 | 1篇 |
1989年 | 4篇 |
1988年 | 2篇 |
1987年 | 7篇 |
1986年 | 3篇 |
1985年 | 5篇 |
1984年 | 7篇 |
1983年 | 1篇 |
1981年 | 2篇 |
1980年 | 2篇 |
1979年 | 2篇 |
1978年 | 2篇 |
1977年 | 2篇 |
排序方式: 共有792条查询结果,搜索用时 18 毫秒
51.
52.
Jocelyn Stockwell Nabiha Abdi Xiaofan Lu Oshin Maheshwari Changiz Taghibiglou 《Chemical biology & drug design》2014,83(5):507-520
For decades, biomedical and pharmaceutical researchers have worked to devise new and more effective therapeutics to treat diseases affecting the central nervous system. The blood–brain barrier effectively protects the brain, but poses a profound challenge to drug delivery across this barrier. Many traditional drugs cannot cross the blood–brain barrier in appreciable concentrations, with less than 1% of most drugs reaching the central nervous system, leading to a lack of available treatments for many central nervous system diseases, such as stroke, neurodegenerative disorders, and brain tumors. Due to the ineffective nature of most treatments for central nervous system disorders, the development of novel drug delivery systems is an area of great interest and active research. Multiple novel strategies show promise for effective central nervous system drug delivery, giving potential for more effective and safer therapies in the future. This review outlines several novel drug delivery techniques, including intranasal drug delivery, nanoparticles, drug modifications, convection‐enhanced infusion, and ultrasound‐mediated drug delivery. It also assesses possible clinical applications, limitations, and examples of current clinical and preclinical research for each of these drug delivery approaches. Improved central nervous system drug delivery is extremely important and will allow for improved treatment of central nervous system diseases, causing improved therapies for those who are affected by central nervous system diseases. 相似文献
53.
Apoptosis pathways and oncolytic adenoviral vectors: promising targets and tools to overcome therapy resistance of malignant melanoma 总被引:2,自引:0,他引:2
Abstract: In the last decades melanoma incidence has been increasing worldwide, while mortality remained on a high level. Until now, there is no suitable therapy for metastasized melanoma, which could lead to a significant increase in overall survival. Apoptosis deficiency is supposed to be a critical factor for therapy resistance, and previous work has characterized the basic mechanisms of apoptosis regulation in melanoma. Genes and strategies suitable for efficient induction of apoptosis in melanoma cells were identified, which are based on proapoptotic Bcl-2 proteins (Bcl-xS , Bcl-xAK , Bik/Nbk and Bax) as well as on tumor necrosis factor (TNF)-related death ligands (CD95L/Fas ligand and TNF-related apoptosis-inducing ligand, TRAIL). Proapoptotic genes may be employed in improved gene therapeutic strategies, based on conditional oncolytic adenoviral vectors. 相似文献
54.
55.
Desensitization of T lymphocyte function by CXCR3 ligands in human hepatocellular carcinoma 总被引:9,自引:0,他引:9
Liu YQ Poon RT Hughes J Li QY Yu WC Fan ST 《World journal of gastroenterology : WJG》2005,11(2):164-170
AIM: Despite the presence of lymphocyte infiltration, human hepatocellular carcinoma (HCC) is typically a rapidly progressive disease. The mechanism of regulation of lymphocyte migration is poorly understood. In this study, we investigated various factors regulating T cell migration in HCC patients. We examined serum CXC chemokine levels in HCC patients and demonstrated the production of CXC chemokines by HCC cell lines. We determined the effect of both HCC patient serum and tumor cell conditioned supernatant upon lymphocyte expression of chemokine receptor CXCR3 as well as lymphocyte migration. Lastly, we examined the chemotactic responses of lymphocytes derived from HCC patients. METHODS: The serum chemokines IP-10 (CXCL10) and Mig (CXCL9) levels were measured by cytometric bead array (CBA) and the tumor tissue IP-10 concentration was measured by ELISA. The surface expression of CXCR3 on lymphocytes was determined by flow cytometry. The migratory function of lymphocytes to the corresponding chemokines was assessed using an in vitro chemotactic assay. Phosphorylation of extracellular signal-regulated kinase (ERK) was determined by Western blot analysis. RESULTS: Increased levels of IP-10 and Mig were detected in HCC patient serum and culture supernatants of HCC cell lines. The IP-10 concentration in the tumor was significantly higher than that in the non-involved adjacent liver tissues. HCC cell lines secreted functional chemokines that induced a CXCR3-specific chemotactic response of lymphocytes. Furthermore, tumor-cell-derived chemokines induced initial rapid phosphorylation of lymphocyte ERK followed by later inhibition of ERK phosphorylation. The culture of normal lymphocytes with HCC cell line supernatants or medium containing serum from HCC patients resulted in a significant reduction in the proportion of lymphocytes exhibiting surface expression of CXCR3. The reduction in T cell expression of CXCR3 resulted in reduced migration toward the ligand IP-10, and both CD4+ and CD8+ T cells from HCC patients exhibited diminished chemotactic responses to IP-10 In vitro compared to T cells from healthy control subjects. CONCLUSION: This study demonstrates functional desensitization of the chemokine receptor CXCR3 in lymphocytes from HCC patients by CXCR3 ligands secreted by tumor cells. This may cause lymphocyte dysfunction and subsequently impaired immune defense against the tumor. 相似文献
56.
目的研究纤连蛋白(FN)对肿瘤坏死因子相关凋亡诱导配体(TRAIL)诱导肝星状细胞fHSC)凋亡的影响及调控机制。方法MTr比色法、流式细胞术检测加入FN时,外源性TRAIL对HSC-T6细胞增殖和诱导细胞凋亡的影响;采用WesternBlot检测粘着斑激酶(FAK)、磷酸化粘着斑激酶(pFAK)、Bax的表达。结果TRAIL可以抑制HSC-T6细胞增殖。可以诱导HSC-T6细胞凋亡,而FN的存在可以使TRAIL诱导的HSC—T6细胞凋亡明显减少(P〈0.05),WesternBlot分析显示TRAIL诱导I-ISC-T6细胞凋亡时加入FN,细胞浆pFAK表达上调而线粒体Bax表达下降。结论FN可以使外源性TRAIL诱导的HSC-T6细胞凋亡减,扮.棚制可能与FN但伸FAK磷酪仙.pFAK表达上调并减少线粒体Bax表达有关。 相似文献
57.
David Brea Miguel Blanco Pedro Ramos-Cabrer Octavio Moldes Susana Arias María Pérez-Mato Rogelio Leira Tomás Sobrino José Castillo 《Journal of cerebral blood flow and metabolism》2011,31(6):1424-1431
Stroke triggers an intense inflammatory response that could be a consequence of Toll-like receptors (TLRs) activation. However, the clinical significance and the therapeutic possibilities of TLR in stroke is not completely clear. In this study, we analyze the association between the expression of TLR2 and TLR4, inflammatory molecules and endogenous ligands, and clinical outcome of ischemic stroke patients, and we test the potential of TLR2/TLR4 and their endogenous ligands as therapeutic targets. For this purpose, we included 110 patients with ischemic stroke finding that TLR2 and TLR4 are independently associated to poor outcome and correlated with higher serum levels of interleukin (IL)1β, IL6, tumor necrosis factor α, and VCAM1, and that TLR4 was independently associated to lesion volume. In addition, we have developed an in vitro model to test the potential therapeutic value of blocking TLR2/TLR4 or their endogenous ligands. Cultured cells (monocytes and human umbilical vein endothelial cells) were treated with serum from ischemic stroke patients, showing a strong inflammatory response that was blocked when TLR2/4 or cellular fibronectin (cFN) or HSP60 were blocked. In conclusion, TLR2 and TLR4 are associated to outcome in stroke patients and TLR2/4 or their endogenous ligands, cFN/HSP60 could be new therapeutic targets for ischemic stroke. 相似文献
58.
The role of interleukin-6 in insulin resistance, body fat distribution and energy balance. 总被引:1,自引:0,他引:1
Interleukin-6 (IL-6) is a central player in the regulation of inflammation, haematopoiesis, immune response and host defense mechanisms. During the last decade, an accumulating amount of data suggested a pivotal role for IL-6 in metabolic processes, thus fortifying the picture of IL-6 as a multifaceted, pleiotropic cytokine. Because of its secretion by adipose tissue and contracting skeletal muscle and its broad action on central and peripheral organs, IL-6 has been termed an adipokine and a myokine. Its quantitative release from adipose tissue results in a subclinical, systemic elevation of IL-6 plasma levels with increasing body fat content, which may be implicated in the proinflammatory state leading to insulin resistance. On the other hand, IL-6 produced in the working muscle during physical activity could act as an energy sensor by activating AMP-activated kinase and enhancing glucose disposal, lipolysis and fat oxidation. In addition, both impaired IL-6 secretion and action are risk factors for weight gain. Thus, IL-6 clearly has lipolytic effects and anti-obesity potential. However, the application of IL-6 itself is at least limited by a narrow therapeutic range and its important function for a balanced inflammatory response. Further studies on the molecular basis of the metabolic effects of IL-6 could elucidate novel therapeutic strategies for custom-designed, IL-6-related substances. 相似文献
59.
利用SELEX技术构建靶向光敏药物 总被引:3,自引:0,他引:3
肿瘤是目前威胁人类健康最凶险的疾病之一.寻找选择性好、副作用小的防治恶性肿瘤的新方法仍然是当今医学研究的热点.光动力学疗法是近年来兴起的极具应用前景的肿瘤治疗新方法.开发新型靶向光敏剂和开展靶向光动力治疗是进一步发展光动力治疗肿瘤的重要方向.本文简述了目前光动力治疗及常用光敏剂的研究现状,并提出通过指数式富集法配体进化技术即SELEX技术构建靶向光敏药物的新设想. 相似文献
60.
Smith FJ Del Monaco M Steijlen PM Munro CS Morvay M Coleman CM Rietveld FJ Uitto J McLean WH 《The British journal of dermatology》1999,141(6):1010-1016
The peripheral benzodiazepine receptor (PBR) is a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. PBR is part of a heteromeric receptor complex involved in the formation of mitochondrial permeability transition pores and in the early events of apoptosis. PBR may function as an oxygen-dependent signal generator; recent data indicate that these receptors may preserve the mitochondria of haematopoietic cell lines from damage caused by oxygen radicals. To identify PBRs in human skin, we used a specific monoclonal antibody directed against the C-terminus fragment of the human receptor. PBR immunoreactivity was found in keratinocytes, Langerhans cells, hair follicles and dermal vascular endothelial cells. Interestingly, confocal microscopic examination of skin sections revealed that PBR expression was strongly upregulated in the superficial differentiated layers of the epidermis. Ultrastructurally, PBRs were distributed throughout the cytoplasm but were selectively expressed on the mitochondrial membranes of epidermal cells. The elevated level of PBRs in the spinous layer was not associated with an increased number of mitochondria nor with an increased amount of mRNA as assessed by in situ hybridization on microautoradiographed skin sections. The present work provides, for the first time, evidence of PBR immunoreactivity in human skin. This mitochondrial receptor may modulate apoptosis in the epidermis; its increased expression in differentiated epidermal layers may represent a novel mechanism of natural skin protection against free radical damage generated by ultraviolet exposure. 相似文献